Abstract The advent of combined antiretroviral therapy (cART) has significantly reduced the incidence of AIDS events, including AIDS-defining malignancies. Nevertheless, several cohort studies conducted in the post cART period have reported an increasing risk of non-AIDS-defining cancers. In immunosuppressed patients, Hodgkin Lymphoma (HL) occurs more frequently than in the general population. HL is associated with Epstein-Barr Virus in most HIV-patients, but inconsistent clinical observations support both a beneficial and detrimental effect of immune restoration on its development. The role of concomitant antiretroviral treatment was clearly demonstrated in the contest of HL chemotherapy, with significant improvement in complete response, overall survival and event-free survival rates when cART and chemotherapy were combined. In the HIV population, as compared to the general population, an improvement has been reported over the last decades, mainly thanks to more available and adequate treatment chances, leading to comparable outcomes.
Franzetti, M., Pandolfo, A., Molteni, C., Castaldo, G., Longoni, E., Bonfanti, P. (2020). Il linfoma di Hodgkin nei soggetti con infezione da HIV. JOURNAL OF HIV AND AGEING(1) [10.19198/JHA31489].
Il linfoma di Hodgkin nei soggetti con infezione da HIV
Bonfanti Paolo
2020
Abstract
Abstract The advent of combined antiretroviral therapy (cART) has significantly reduced the incidence of AIDS events, including AIDS-defining malignancies. Nevertheless, several cohort studies conducted in the post cART period have reported an increasing risk of non-AIDS-defining cancers. In immunosuppressed patients, Hodgkin Lymphoma (HL) occurs more frequently than in the general population. HL is associated with Epstein-Barr Virus in most HIV-patients, but inconsistent clinical observations support both a beneficial and detrimental effect of immune restoration on its development. The role of concomitant antiretroviral treatment was clearly demonstrated in the contest of HL chemotherapy, with significant improvement in complete response, overall survival and event-free survival rates when cART and chemotherapy were combined. In the HIV population, as compared to the general population, an improvement has been reported over the last decades, mainly thanks to more available and adequate treatment chances, leading to comparable outcomes.File | Dimensione | Formato | |
---|---|---|---|
Franzetti JHA 2020.pdf
accesso aperto
Tipologia di allegato:
Publisher’s Version (Version of Record, VoR)
Dimensione
191.46 kB
Formato
Adobe PDF
|
191.46 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.